Eagle Genomics Gains Microsoft Co-Sell Status for Microbiome Mapping AI Platform
Crescendo Biologics Strenghthens its Management team
Using Public Money to Leverage Private Finance into our Portfolio
We have leveraged £200+ million of private investment to create more than 40 companies.
Astellas Announces Acquisition of Quethera
UKI2S announces seed investment in Cagen
CellCentric raises $26m for new late-state prostate cancer drug
... the UK Minstry of Defence (MoD) through the Defence Science and Technology Laboratory...
Peter's is the first spin-out from the James Hutton Institute to secure a Converge...